BiOraliX Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

BiOraliX General Information

Description

Developer of oral delivery technology intended for protein therapeutics. The company's technology utilizes supercritical spray drying, protein encapsulation, nanoparticle production, enteric coating, and bioavailability enhancement, providing pharmaceutical companies with biopharmaceutical formulations to enable oral administration of complex biologics.

Contact Information

Website
www.bioralix.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Verlaat 1
  • 8428 RS Fochteloo
  • Netherlands
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Acquirer
BiosanaPharma
Vertical(s)
Life Sciences
Corporate Office
  • Verlaat 1
  • 8428 RS Fochteloo
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BiOraliX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BiOraliX‘s full profile, request access.

Request a free trial

BiOraliX Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

BiOraliX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3880233-A1 Formulations of biological polymers for oral administration Inactive 22-Jun-2018
US-11793758-B2 Formulations of biological polymers for oral administration Active 22-Jun-2018
US-20210259973-A1 Formulations of biological polymers for oral administration Active 22-Jun-2018
WO-2019245373-A1 Formulations of biological polymers for oral administration Inactive 22-Jun-2018 A61K9/1623

BiOraliX Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BiOraliX‘s full profile, request access.

Request a free trial

BiOraliX FAQs

  • When was BiOraliX founded?

    BiOraliX was founded in 2017.

  • Where is BiOraliX headquartered?

    BiOraliX is headquartered in Fochteloo, Netherlands.

  • What industry is BiOraliX in?

    BiOraliX’s primary industry is Drug Delivery.

  • Is BiOraliX a private or public company?

    BiOraliX is a Private company.

  • What is BiOraliX’s current revenue?

    The current revenue for BiOraliX is .

  • Who are BiOraliX’s investors?

    InProPharma has invested in BiOraliX.

  • When was BiOraliX acquired?

    BiOraliX was acquired on 01-Jan-2018.

  • Who acquired BiOraliX?

    BiOraliX was acquired by BiosanaPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process